In this SBIR Phase II PicoCal will develop a high throughput apparatus to measure changes in cell adhesion at the level of individual receptor-ligand interactions in real time. This tool finds critical applications in research and drug development and would allow researchers to study and manipulate adhesion by bioactive compounds to promote or inhibit physiological processes. There is a significant industrial and scientific need to detect changes that can be induced by chemokines or other highly bioactive compounds in order to elucidate the different pathways of signaling mechanisms within a cell and to screen for new key compounds interfering with such pathways. These findings may help to develop new therapies for cancer, arteriosclerosis, and autoimmune diseases, like rheumatoid arthritis. In research and drug development scientists have to study thousands of compounds to determine, if a compound activates or inhibits adhesion. In addition, many diseases such as cancer are complex and require testing multiple analytes and new key compounds for accurate drug development and treatment. There is a need for new tools in drug development to identify bio- active compounds that inhibit or promote adhesion - or modulate subtle changes in receptor affinity. The instrument can also aid researchers in studying the mechanisms of cell adhesion changes such as in tumor promotion and organ-specific metastasis. Key research and pharmaceutical applications include: leukocyte and hematopoietic stem cell adhesion to blood vessels, as well as to other cells (bone marrow niche) or to extracellular matrix (ECM) proteins, platelet adhesion, bacteria and micro-organism adhesion (bio-fouling).

Public Health Relevance

PicoCal Inc. will develop an apparatus that finds critical applications in research and drug development. The instrument can aid researchers in studying the mechanisms of cancer metastasis, atherosclerotic coronary artery disease, and bacteria and micro-organism adhesion (bio-fouling) among others. These findings may help develop new therapies for cancer, arteriosclerosis, and autoimmune diseases, like rheumatoid arthritis.

Agency
National Institute of Health (NIH)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44GM084520-04
Application #
8744279
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Flicker, Paula F
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Picocal, Inc.
Department
Type
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33199
Kim, Gwangseong; Gaitas, Angelo (2015) Extracorporeal photo-immunotherapy for circulating tumor cells. PLoS One 10:e0127219
Gaitas, Angelo; Kim, Gwangseong (2015) Chemically Modified Plastic Tube for High Volume Removal and Collection of Circulating Tumor Cells. PLoS One 10:e0133194
Gaitas, Angelo; Malhotra, Ricky; Li, Tao et al. (2015) A device for rapid and quantitative measurement of cardiac myocyte contractility. Rev Sci Instrum 86:034302
Gaitas, Angelo; Kim, Gwangseong (2015) Inductive heating kills cells that contribute to plaque: a proof-of-concept. PeerJ 3:e929
Gaitas, Angelo; Malhotra, Ricky; Pienta, Kenneth et al. (2014) Response to "Comment on 'A method to measure cellular adhesion utilizing a polymer micro-cantilever'" [Appl. Phys. Lett. 104, 236103 (2014)]. Appl Phys Lett 104:236104
Gaitas, Angelo; Hower, Robert W (2014) SU-8 microcantilever with an aperture, fluidic channel, and sensing mechanisms for biological and other applications. J Micro Nanolithogr MEMS MOEMS 13:
Gaitas, Angelo; Malhotra, Ricky; Pienta, Kenneth (2013) A method to measure cellular adhesion utilizing a polymer micro-cantilever. Appl Phys Lett 103:123702